Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2005-03-15
2005-03-15
Webman, Edward J. (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C514S159000, C514S162000, C514S165000, C514S226500, C514S356000, C514S357000, C514S365000, C514S370000, C514S375000, C514S400000, C514S404000, C514S419000, C514S420000, C514S423000, C514S428000, C514S429000, C514S448000, C514S471000, C514S567000, C514S569000
Reexamination Certificate
active
06867236
ABSTRACT:
The present invention relates, in general, to a method of preventing or delaying the onset of Alzheimer's disease and related neurodegenerative disorders. The invention also relates to a method of treating Alzheimer's disease and related neurodegenerative disorders so as to ameliorate the further progress of symptoms. The methods involve the administration of a non-steroidal anti-inflammatory agent and/or a histamine H2 receptor blocking agent. According to indication, the present method can be applied to individuals who are currently asymptomatic but at risk of developing Alzheimer's disease, to individuals who have mild cognitive symptoms that may either denote an incipient prodrome of Alzheimer's disease or represent early symptoms (prodromal stage), or to individuals who have a clinical diagnosis of Alzheimer's disease.
REFERENCES:
patent: 5190960 (1993-03-01), Guillaumet et al.
patent: 5192753 (1993-03-01), McGeer et al.
patent: 5225571 (1993-07-01), Lee
patent: 5229401 (1993-07-01), Effland et al.
patent: 5258400 (1993-11-01), Garst et al.
patent: 5258513 (1993-11-01), Van Keulen et al.
patent: 5352688 (1994-10-01), Kaminski
patent: 5643960 (1997-07-01), Breitner et al.
patent: 6025395 (2000-02-01), Breitner et al.
CA 113:17731, Yanagawa et al., Feb. 1990.*
McGeer et al, Anti-inflammatory drugs and Alzheimer's disease, The Lancet 335:1037 (1990).
Schnabel, J., “New Alzheimer's Therapy Suggested”, Science 260:1719 (1993).
Gordon, M.N., “Microglia and Immune Activation in Alzheimer's Disease”, J. Florida M.A. 80(4):267 (1993).
Vane, “Towards a better aspirin”, Nature 367:215 (1994).
Yanagawa et al, CA 113:17731 (1990).
Breitner et al, “Delayed Onset of Alzheimer's Disease With Nonsteroidal Anti-Inflammatory and Histamine H2 Blocking Drugs”, Neurobiology of Aging 16(4):523-530 (1995).
Breitner John C. S.
Welsh-Bohmer Kathleen A.
Duke University
Webman Edward J.
LandOfFree
Method of preventing of delaying the onset and progression... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of preventing of delaying the onset and progression..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of preventing of delaying the onset and progression... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3419154